
The 3rd Global Clinical Oncology Conference (GCOC 2027), 17–19 March 2027, Singapore
GCOC 2027: Advancing Global Clinical Oncology Through Innovation, Collaboration, and Cutting-Edge Cancer Research
The Organizing Committee is pleased to welcome researchers, clinicians, oncologists, healthcare professionals, and other experts from around the world to the 3rd Global Clinical Oncology Conference (GCOC 2027), which will take place from 17 to 19 March 2027 in Singapore, in a hybrid format.
The GCOC 2027 will feature a comprehensive three-day scientific program, including a Plenary Forum, 18 thematic breakout streams, and a poster exhibition. The conference will provide an international platform for sharing the latest scientific findings, discussing emerging clinical advances, and fostering collaboration in oncology research and practice.
The scientific program will cover a broad range of topics, including cancer epidemiology and prevention, cancer biomarkers and diagnostics, gastrointestinal cancer, cancer therapy and treatment, breast cancer, and other related areas. Through keynote presentations, oral sessions, and poster discussions, participants will have opportunities to exchange knowledge, explore innovative approaches, and discuss current challenges and future directions in clinical oncology.
The GCOC 2027 welcomes participants to attend in person or virtually via Zoom, providing opportunities for international engagement and scientific exchange regardless of location. We look forward to bringing together experts and colleagues from across the global oncology community to advance cancer research and improve clinical practice.
Conference information:
- Date: 17–19 March 2027
- Location: Singapore
- Venue: Holiday Inn Singapore Atrium
- Format: Hybrid (On-site and Online)
- Website: https://gcoc2027.lmsii.org/
Contact information:
- Contact Person: Ms. Ava Siu
- Email: ava@lmsii.com